{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:18:55Z","timestamp":1777933135978,"version":"3.51.4"},"reference-count":26,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijdvl.ijdvl_813_16","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T05:19:17Z","timestamp":1509427157000},"page":"696","source":"Crossref","is-referenced-by-count":3,"title":["Study of the relation between two common cyclooxygenase 2 gene polymorphisms with risk of developing and subtypes of vitiligo in Egyptian patients"],"prefix":"10.25259","volume":"84","author":[{"given":"SamarAbdallah","family":"M Salem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DaliaGamal","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KhaldaSayed","family":"Amr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MahmoundFawzy","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.217473-1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","article-title":"Clinical practice.Vitiligo","author":"Ta\u00efeb","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0378-6323.217473-2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.10.001","article-title":"Physiopathology and genetics of vitiligo","author":"Passeron","year":"2005","journal-title":"J Autoimmun"},{"key":"key-10.4103\/0378-6323.217473-3","doi-asserted-by":"crossref","unstructured":"Khunger N. Vitiligo surgery. In: Robinson JK, editor. Surgery of the Skin: Procedural Dermatology. 2nd ed. UK: Elsevier Health Sciences; 2010. p. 683-92.","DOI":"10.1016\/B978-0-323-06575-7.00042-0"},{"key":"key-10.4103\/0378-6323.217473-4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgg.2011.05.005","article-title":"Recent progress in the genetics of generalized vitiligo","author":"Spritz","year":"2011","journal-title":"J Genet Genomics"},{"key":"key-10.4103\/0378-6323.217473-5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/pdia.2014.43497","article-title":"Current aspects of vitiligo genetics","author":"Czajkowski","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"key-10.4103\/0378-6323.217473-6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-4362.2002.01612.x","article-title":"Topical prostaglandin analog (PGE2) in vitiligo \u2013 A preliminary study","author":"Parsad","year":"2002","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.217473-7","first-page":"35","article-title":"Prostaglandin E2 regulates the expression of basic fibroblast growth factor messenger RNA in normal human fibroblasts","author":"Sakai","year":"2001","journal-title":"Kobe J Med Sci"},{"key":"key-10.4103\/0378-6323.217473-8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF02505269","article-title":"Basic fibroblast growth factor promotes melanin synthesis by melanocytes","author":"Puri","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"key-10.4103\/0378-6323.217473-9","doi-asserted-by":"crossref","first-page":"C1392","DOI":"10.1152\/ajpcell.1994.266.5.C1392","article-title":"Prostaglandin E2 synthesis after oxidant stress is dependent on cell glutathione content","author":"Hempel","year":"1994","journal-title":"Am J Physiol"},{"key":"key-10.4103\/0378-6323.217473-10","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1038\/jid.2014.192","article-title":"Cyclooxygenases: Mediators of UV-induced skin cancer and potential targets for prevention","author":"Elmets","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.217473-11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2008.08923.x","article-title":"Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo","author":"Kapoor","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.217473-12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/ijd.12631","article-title":"The effect of latanoprost on vitiligo: A preliminary comparative study","author":"Anbar","year":"2015","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/0378-6323.217473-13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0005-2760(91)90032-D","article-title":"Prostaglandin endoperoxide synthase: Regulation of enzyme expression","author":"DeWitt","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"key-10.4103\/0378-6323.217473-14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gene.2014.04.014","article-title":"COX-2 polymorphisms -765G\u2192C and -1195A\u2192G and hepatocellular carcinoma risk","author":"Gharib","year":"2014","journal-title":"Gene"},{"key":"key-10.4103\/0378-6323.217473-15","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s11033-013-2991-7","article-title":"Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt","author":"Mohamed","year":"2014","journal-title":"Mol Biol Rep"},{"key":"key-10.4103\/0378-6323.217473-16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1751-1097.2007.00261.x","article-title":"Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis","author":"Rundhaug","year":"2008","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0378-6323.217473-17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1562\/0031-8655(2002)076<0073:CEIMAH>2.0.CO;2","article-title":"Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches","author":"An","year":"2002","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0378-6323.217473-18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.0022-202X.2005.23960.x","article-title":"Selective cyclooxygenase-2 inhibition produces heterogeneous erythema response to ultraviolet irradiation","author":"Rodriguez-Burford","year":"2005","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0378-6323.217473-19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10555-011-9317-9","article-title":"The role of the EP receptors for prostaglandin E2 in skin and skin cancer","author":"Rundhaug","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"key-10.4103\/0378-6323.217473-20","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1006\/geno.1994.1569","article-title":"Assignment of the human prostaglandin-endoperoxide synthase 2 (PTGS2) gene to 1q25 by fluorescence in situ hybridization","author":"Tay","year":"1994","journal-title":"Genomics"},{"key":"key-10.4103\/0378-6323.217473-21","first-page":"565","article-title":"Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer","author":"Zhang","year":"2005","journal-title":"Gastroenterology"},{"key":"key-10.4103\/0378-6323.217473-22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaci.2005.03.010","article-title":"Association of COX-2 gene haplotypes with prostaglandins production in bronchial asthma","author":"Sanak","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"key-10.4103\/0378-6323.217473-23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6601906","article-title":"Polymorphisms in prostaglandin synthase 2\/cyclooxygenase 2 (PTGS2\/COX2) and risk of colorectal cancer","author":"Cox","year":"2004","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0378-6323.217473-24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgh100","article-title":"COX-2 gene promoter haplotypes and prostate cancer risk","author":"Panguluri","year":"2004","journal-title":"Carcinogenesis"},{"key":"key-10.4103\/0378-6323.217473-25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jdermsci.2008.09.010","article-title":"Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations","author":"Li","year":"2009","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/0378-6323.217473-26","first-page":"323","article-title":"Clinical predictors of outcome in vitiligo","author":"Dave","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:43:24Z","timestamp":1611917004000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/study-of-the-relation-between-two-common-cyclooxygenase-2-gene-polymorphisms-with-risk-of-developing-and-subtypes-of-vitiligo-in-egyptian-patients\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"alternative-id":["217473"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_813_16","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}